Literature DB >> 15852028

Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation.

X P Ju1, B Xu, Z P Xiao, J Y Li, L Chen, S Q Lu, Z X Huang.   

Abstract

Acute graft-versus-host disease (aGVHD) is one of the major problems following allogeneic peripheral blood stem cell transplantation (allo-PBSCT). In order to investigate the pathogenesis of human aGVHD, we analyzed cytokine gene expression and cytokine secretion by peripheral blood mononuclear cells (PBMC) in 30 patients who underwent allo-PBSCT. In this study, reverse transcription-polymerase chain reaction (RT-PCR) was used to explore the mRNA expression of interleukin (IL)-2, interferon (IFN)-gamma, IL-4, IL-10 and IL-12 in the PBMC of allo-PBSCT patients with aGVHD and in controls. The concentrations of these cytokines and of IL-18 were also measured by means of ELISA in medium obtained from cultured leukocytes after stimulation with PHA or LPS. Compared with the normal allo-PBSCT group (n=14), IL-2 and IFN-gamma were detected more frequently in aGVHD group (n=16). IL-12 and IL-18 were elevated, while IL-10 level decreased in the same group. There is no difference in IL-4 gene expression between patients with or without aGVHD, but the concentration of IL-4 for patients with grade II-IV aGVHD decreased. These data suggest that IL-2, IFN-gamma, IL-12 and IL-18 play important roles in the development of aGVHD in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15852028     DOI: 10.1038/sj.bmt.1704972

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  16 in total

1.  HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation.

Authors:  Danielle M Zerr; Michael Boeckh; Colleen Delaney; Paul J Martin; Hu Xie; Amanda L Adler; Meei-Li Huang; Lawrence Corey; Wendy M Leisenring
Journal:  Biol Blood Marrow Transplant       Date:  2012-05-26       Impact factor: 5.742

2.  CXCL10 can be detected non-invasively from the skin of children with acute skin GvHD.

Authors:  P Khandelwal; K Smiley; A M Fieno; R A Grant; S M Davies
Journal:  Bone Marrow Transplant       Date:  2016-05-09       Impact factor: 5.483

3.  Nuclear factor-kappaB inducing kinase is required for graft-versus-host disease.

Authors:  Carmen Sánchez-Valdepeñas; Lucía Casanova; Isabel Colmenero; Mar Arriero; Africa González; Nieves Lozano; Marta González-Vicent; Miguel A Díaz; Luís Madero; Manuel Fresno; Manuel Ramírez
Journal:  Haematologica       Date:  2010-09-07       Impact factor: 9.941

4.  Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor.

Authors:  Eli C Lewis; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

5.  Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation.

Authors:  Courtney M Lappas; Po-Ching Liu; Joel Linden; Elizabeth M Kang; Harry L Malech
Journal:  J Leukoc Biol       Date:  2009-11-04       Impact factor: 4.962

6.  Proinflammatory cytokines as potential risk factors of acute graft-versus-host disease and infectious complications after allogeneic hematopoietic stem cell transplantation.

Authors:  Malwina Rybicka-Ramos; Miroslaw Markiewicz; Aleksandra Suszka-Switek; Ryszard Wiaderkiewicz; Sylwia Mizia; Monika Dzierzak-Mietla; Krzysztof Bialas
Journal:  Am J Blood Res       Date:  2021-04-15

7.  Role of CD8 Regulatory T Cells versus Tc1 and Tc17 Cells in the Development of Human Graft-versus-Host Disease.

Authors:  Adriana Gutiérrez-Hoya; Rubén López-Santiago; Jorge Vela-Ojeda; Laura Montiel-Cervantes; Octavio Rodríguez-Cortés; Víctor Rosales-García; Vladimir Paredes-Cervantes; Raúl Flores-Mejía; Daniela Sandoval-Borrego; Martha Moreno-Lafont
Journal:  J Immunol Res       Date:  2017-01-09       Impact factor: 4.818

8.  The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA-identical sibling donors: results of the HOVON-107 study.

Authors:  Georgine E de Greef; Eric Braakman; Bronno van der Holt; Jeroen J W M Janssen; Eefke Petersen; Vladimir Vucinic; Nicole Thuss; Meriam Grootes; Jan J Cornelissen
Journal:  Transfusion       Date:  2018-12-11       Impact factor: 3.157

9.  Risk Factors for Graft-Versus-Host Disease After Transplantation of Hematopoietic Stem Cells from Unrelated Donors in the China Marrow Donor Program.

Authors:  Fan Yang; Daopei Lu; Yu Hu; Xiaojun Huang; He Huang; Jing Chen; Depei Wu; Jianmin Wang; Chun Wang; Mingzhe Han; Hu Chen
Journal:  Ann Transplant       Date:  2017-06-27       Impact factor: 1.530

10.  Therapeutic effects of STAT3 inhibition by nifuroxazide on murine acute graft graft-vs.-host disease: Old drug, new use.

Authors:  Huijie Jia; Jing Cui; Xiaolong Jia; Jingjing Zhao; Yuchen Feng; Peijuan Zhao; Dan Zang; Jian Yu; Tiesuo Zhao; Hui Wang; Kailin Xu
Journal:  Mol Med Rep       Date:  2017-10-19       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.